The amplified expression of factors regulating myogenesis in L6 myoblasts by unknown
RAPID  COMMUNICA TIONS 
The Amplified 
Myogenesis in 
Expression of Factors Regulating 
L6 Myoblasts 
WOODRING  E.  WRIGHT 
Departments of Cell Biology and Internal Medicine, The University of Texas Southwestern Medical School, Dallas 75235 
ABSTRACT  A strategy for increasing the expression of the factors regulating myogenesis was devel- 
oped based upon the observation that increased amounts of regulatory factors could overcome the 
inhibition  of  differentiation  produced  by  5-bromodeoxyuridine  (BUdR). L6  rat  myoblasts were 
subjected to multiple  cycles of cloning in progressively increasing concentrations of BUdR. The first 
clones to differentiate  were picked and replated for the next cycle of selection. After 28 cycles in 
BUdR, cells were  isolated that  could  differentiate  in  the  presence of 8 #M  BUdR. Cell hybrids 
between  myoblasts subjected  to 21  cycles of selection (BU21 cells) and differentiation-defective 
myoblasts exhibited  a high probability  of differentiation,  consistent with the hypothesis that BU21 
cells were overproducing  factor(s) involved  in the decision to differentiate.  The selection of cells 
able to differentiate  in the presence of BUdR may provide  a general approach for increasing the 
expression of the regulatory molecules controlling terminal differentiation. 
The process of terminal cell differentiation almost certainly 
involves multiple events before differentiation is finally initi- 
ated. A great deal of progress has been made using molecular 
approaches toward understanding the factors (enhancers, pro- 
moters, methylation sites, etc.) that influence gene regulation 
at  the  final  stage  of cell differentiation: the  expression of 
structural genes.  However, the lack of suitable experimental 
models has made it difficult to apply molecular techniques to 
earlier stages when the actual decision to differentiate is made. 
We here report the development of a model system in which 
the factors influencing the decision to commit to and execute 
terminal myogenesis should be amenable to study. 
The development of this experimental system derived from 
two  series  of observations into  the  behavior of myogenic 
hybrids and  heterokaryons.  In  the  first,  cell  hybrids were 
formed between differentiation-defective  and differentiation- 
competent myoblasts. These hybrids exhibited a frequency of 
differentiation (1%) that was  60-fold less than that seen in 
competent x  competent hybrids (64%) and 20-fold greater 
than that seen in defective x  defective hybrids (0.05%).  We 
proposed a molecular model for the regulation of the proba- 
bility of  differentiation to explain these results (1). This model 
required that the induced level of a critical regulatory factor 
must be reduced in differentiation-defective  myoblasts. Since 
differentiation-defective variants arise with a high frequency 
(2),  this  in  turn  suggested  that  the  induced  level  of this 
molecule(s) is controlled by a mechanism that also varies with 
a high frequency. Assuming that there is no intrinsic direc- 
tionality  in  this  variation,  the  ability  to  isolate myoblasts 
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producing very low levels (differentiation-defective  myoblasts) 
implied that it should also be possible to isolate myoblasts 
producing very high levels (amplified myoblasts). 
A second series of cell fusion experiments provided a strat- 
egy for isolating such myoblasts with an increased expression 
of the factors regulating terminal differentiation. 5-bromode- 
oxyuridine (BUdR) ~ inhibits cell differentiation in a variety 
of  systems,  including  myogenesis.  Although  rat  skeletal 
myosin light chain synthesis is normally induced in hetero- 
karyons formed by fusing mononucleated differentiated chick 
myocytes to undifferentiated rat myoblasts (3, 4), this induc- 
tion is blocked if the rat myoblasts are grown in BUdR prior 
to cell fusion (5). However, the ability to induce rat myosin 
light chain synthesis is regained if binucleated differentiated 
chick myocytes are fused to BUdR-blocked rat myoblasts (5). 
This suggested  that increased amounts of regulatory factors 
could overcome the inhibition of differentiation produced by 
BUdR. 
The results of the  experiments involving BUdR-blocked 
myoblasts implied that if L6 myoblasts were cloned in the 
presence of BUdR, those cells with the highest amounts of 
the factors regulating cell differentiation should be able to 
overcome the inhibition of myogenesis produced by a  low 
concentration of BUdR. The variable regulation of the level 
of these molecules suggested  by the experiments involving 
differentiation-defective  myoblasts  implied  that  repeated 
cycles of selection  in  increasing  concentrations  of BUdR 
Abbreviation used in this paper: BUdR, 5-bromodeoxyuridine. 
311 might result in a progressively amplified expression (with or 
without actual gene-amplification [6]) of these molecules. We 
here  report the  successful isolation and  characterization  of 
myoblasts able to differentiate in the presence of BUdR and 
which exhibit a dominant behavior when fused to differentia- 
tion-defective myoblasts, consistent  with  the  interpretation 
that they have an increased expression of  the factors regulating 
terminal myogenic differentiation. 
MATERIALS  AND  METHODS 
L6 rat myoblasts (7) were grown in medium containing four parts Dulbeceo's 
modified Eagle's medium to one part medium 199, 10% fetal calf serum, 100 
~g/ml  streptomycin, and  100  #g/ml  penicillin.  BUdR-resistant  cells  were 
isolated during repeated cycles of cloning. At each cycle, approximately  1,000- 
10,000 colonies in one 150-cm  2 petri dish were visually screened on the day(s) 
on which previous cycles indicated differentiation  would first start to occur. 
Typically, 10-20 colonies containing myotubes were identified and circled with 
a fine tipped pen. Because the selection protocol did not require true clones, 
even colonies with an immediately adjacent colony were marked.  Adjacent 
nonmyotube containing colonies were then scraped off the dish using the fire- 
polished tip of a drawn out sterile Pasteur pipet under direct observation  using 
a 4  x  objective.  The marked colonies were trypsinized  within glass cloning 
cylinders  sealed  to the bottom of the dish with sterile  vaseline.  All of the 
trypsinized  colonies were then mixed together and replated  in 2-3  150-cm  2 
petri dishes for the next cycle of selection. A variety of factors motivated the 
decision to pick and pool multiple colonies at each cycle: (a) The identification 
of a small multinucleated cell as a myotube was often ambiguous, particularly 
during the initial cycles of  selection in BUdR; combining many colonies  diluted 
the effect of any mistaken judgment. (b) Since local cell density is one of the 
most important factors influencing cell differentiation,  the probability  of dif- 
ferentiation  of a  well isolated  colony might be different from that of two 
adjacent colonies.  The cells were plated at the highest practical  density,  thus 
colonies  with  adjacent  colonies were  not  infrequent.  Picking  and  mixing 
multiple colonies diluted the effect of choosing a  colony that differentiated 
precociously  primarily  because it was  next to  another colony rather than 
because  it was expressing  an  increased  propensity to differentiate.  (c)  The 
probability of obtaining a variant is proportional to the number of  cells studied. 
Picking 10-20 colonies thus increased the probability of  a shift in gene expres- 
sion 10-20-fold as compared with picking a single colony, without requiring 
the time delay that would have been incurred by expanding a single colony to 
an equivalent cell number. 
Part of  the toxicity of  BUdR has been ascribed to its inhibition ofthymidylate 
synthetase and the consequent reduction in intracellular  deoxycytidine  (8). 
Since the cells began exhibiting toxic effects (slowed growth rate and a more 
flattened  morphology with apparent stress fibers) under clonal growth condi- 
tions in 0.25  uM BUdR, 200 #M deoxycytidine  was added to the medium 
during subsequent cycles. We have shown that this concentration of deoxycy- 
tidine only produces a slight decrease  in the degree of BUdR for thymidine 
substitution in the DNA of L6 myoblasts and does not reverse the inhibition 
of differentiation  produced by BUdR (9). The degree of BUdR for thymidine 
substitution was determined on cesium chloride gradients  (9). Manipulations 
involving BUdR were performed in a room fitted with gold fluorescent lighting 
(Sylvania gold rapid-start  lamps) and using microscopes fitted with filters that 
blocked the transmission of light of <550 nm. 
Cell hybrids were constructed, karyotyped,  and  stained with antimyosin 
antibodies as described elsewhere (1). Briefly, highly purified  populations of 
heterokaryons were isolated by exploiting the complementation between the 
lethal effects of two different irreversible biochemical  inhibitor's (10,  11). The 
heterokaryons were then cloned in 96-well plates and expanded into several 2- 
cm  2 wells, one of which was karyotypcd  in situ. Clones containing a chromo- 
some number appropriate for hybrids between the parental  cells were then 
replated at clonal density and allowed to grow for 2 wk to form large colonies, 
then stimulated to differentiate  by feeding with medium containing I% fetal 
bovine serum and 5 ~g/ml insulin (12).  1 wk later the cells were fixed and 
stained with the monoclonal antimyosin antibody CCM-52(13)  (generously 
provided by R. Zak, University of Chicago, IL) using an avidin-biotin-peroxi- 
dase detection system (Vectastaln, Vector Laboritories, Burlingame, CA). This 
permitted both the fraction  of myosin-positive  subclones and the fraction  of 
myosin-positive cells to be quantitated. 
RESULTS 
After an initial round of selection of L6 rat myoblasts in the 
absence of BUdR  to  obtain  a  pool  of well-differentiating 
clones,  two  cycles of selection  in  0.5  ~M  BUdR  were  per- 
formed. This concentration inhibited myotube  formation by 
50% under mass culture conditions (9). Although some clones 
containing  possible  myotubes  were  picked  after  15-16-d 
growth at each cycle, the extent of myotube  formation was so 
limited under these clonal conditions as to  make  the identi- 
fication  of  myotube-containing  clones  ambiguous.  Several 
additional  cycles of selection in the  absence of BUdR  were 
then  performed  to  isolate  myoblasts with  an  increased pro- 
pensity  to  differentiate  before  reinstituting  the  selection  in 
BUdR.  After seven cycles of selection, ED7 cells (early differ- 
entiating,  seven  cycles  of  selection)  were  obtained  which 
showed myotube  formation as early as 6-7  d  after plating in 
colonies occasionally containing as few as  100 cells. The ED7 
cells were  then  used  as  the  starting  cell  population  for  the 
cycles of BUdR  selection.  The  presence of 0.25  uM  BUdR 
increased the time required for ED7 cells to differentiate from 
6-7  d  to  12  d.  The  concentration  of BUdR  was  gradually 
increased to 8 uM BUdR by alternating cycles in which clones 
were selected for their ability to differentiate at shorter times 
with  cycles in  which  they  were  selected for  their  ability  to 
differentiate in higher concentrations of BUdR  (Fig.  1). 
The density of the DNA  was determined on cesium chloride 
gradients at cycle BU25 to verify that the cells were incorpo- 
rating  BUdR  normally.  DNA  from  BU25  cells grown  in  2 
#M  BUdR  plus  200  ~zM  deoxycytidine  (see  Materials  and 
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FIGURE  1  Selection  history  of cells able to differ- 
entiate in the presence  of BUdR. At each cycle of 
selection the first  10-20 clones exhibiting myotube 
iormation  were  picked,  pooled,  and  replated  at 
clonal densities  for the  next cycle.  The myotubes 
formed during cycles two and three were so small 
and ambiguous that the use of BUdR was temporarily 
discontinued and clones were isolated simply based 
on their capacity  to  differentiate at  low local  cell 
densities  ED,  early differentiating. ED  cycle  seven 
cells  then formed  the  starting  material  for  a  new 
series of selection cycles in the presence of BUdR. 100' 
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Time dependence of clonal differentiation of L6  and 
BU21 myoblasts. L6 and  BU21 myoblasts were plated in  multiple 
dishes at 500 cells per 60-mm petri dish in medium with or without 
2/LM BUdR and 20/~M deoxycytidine. Approximately 160 colonies 
(eight colonies per cm 2) formed per plate. Dishes were fixed, giemsa 
stained, and counted to determine the percent of colonies contain- 
ing myotubes. A myotube was defined as a cell containing more 
than three nuclei. BU21 cells  differentiate at earlier times  in  the 
presence of 2 #M BUdR than the parental  L6 myoblasts do in  its 
absence. 
FIGURE 2  BUdR  "dependence" of  BU21 cells.  L6  myoblasts  or 
cells isolated after 21 cycles of selection in BUdR (BU21 cells) were 
plated at clonal densities in the absence of BUdR, then fixed and 
giemsa-stained  on the day that  myotube colonies were first  ob- 
served. (A and B) L6 myoblasts fixed 10 d after plating. (C-F) BU21 
myoblasts fixed 4 d after plating.  Although most of the myotube- 
containing BU21 colonies had mixtures of differentiated and undif- 
ferentiated cells  (C-EL occasional  colonies were totally differen- 
tiated (F). Bar, 100 #m. 
Methods) showed a density shift of 0.0239 g/ml, correspond- 
ing to a  27%  BUdR for thymidine substitution.  This  was 
slightly less than the 36%  substitution obtained with control 
L6 myoblasts grown under the same conditions. Although a 
small part of the resistance  to BUdR might have been a result 
of this lowered incorporation, the cells were  nonetheless in- 
corporating 75% of the expected amount of BUdR into their 
DNA. 
Following 21  cycles of selection,  cells were  obtained that 
began forming myotubes 6-7 d after being plated at clonal 
densities  in 2 gM BUdR. These BU21  myoblasts were essen- 
tially BUdR-dependent for cell growth rather than differentia- 
tion. When cloned in the absence of BUdR, small  colonies 
containing fewer than 20 nuclei,  half of which were already 
in  a  myotube,  were  formed  after  3-4  d  growth.  Colonies 
consisting of no mononucleated cells and a  single myotube 
containing 3-4  nuclei  were  occasionally observed 3 d  after 
cloning.  Since  no  multinucleated  myotubes were  observed 
during the first  2 d,  these  myotubes were not preformed in 
the initial  cell population but represented cells that may have 
been producing so much of a  regulatory factor(s)  that they 
differentiated  once the  BUdR  was  removed.  Fig.  2  shows 
some representative colonies of the initial  L6 myoblasts and 
BU21  cells  grown  in  the  absence  of BUdR.  Although L6 
parental cells were completely inhibited during clonal growth 
by 2/zM BUdR, BU21 cells differentiated at shorter times of 
clonal growth in the presence of 2 ~M BUdR than L6 cells 
did in the absence of BUdR (Fig. 3). This difference  is even 
more impressive  when the data of Fig. 4 are replotted as a 
function of colony size (Fig. 4). 
A shift in chromosome number occurred during the isola- 
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FIGURE 4  Colony size dependence of clonal differentiation of L6 
and  BU21 myoblasts. Colony sizes from the experiment of Fig. 4 
were detemined in two ways. For time points of less than 6 d, all 
of the nuclei in  10-20 colonies from the fixed and stained dishes 
were counted, and the average colony size calculated.  For later 
time points,  sister dishes were trypsinized and total cell number 
determined using a Coulter Counter (Model ZBI, Coulter Electron- 
ics, Inc., Lehigh Valley, PA).  Average colony size was then calculated 
by dividing total cells by the number of colonies per plate. 
tion of BU21  variants.  Whereas our parental  L6 myoblasts 
have a  modal number of 41  chromosomes (14),  the  BU21 
cells had 65 (range 56 to 69). The shift  to increased ploidy 
occurred before the  cells  became resistant  to  BUdR,  since 
ED7 cells had 75 chromosome (range 66 to 87). The ability 
to differentiate  in the presence of 2 ~M  BUdR is thus not a 
simple consequence of a gross increase  in chromosome num- 
ber. However, in the absence of detailed  banding studies, we 
cannot know whether potential gene dosage effects  due  to 
increased  numbers of specific chromosomes were present.  No 
double minute chromosomes were observed in either ED7 or 
BU21 cells. 
The relative  dominance of the BUdR-resistant phenotype 
was examined in cell hybrids. Because  an increase  in chro- 
mosome number had occurred in BU21  cells, three sets of 
hybrids were  constructed: BU21  x  differentiation-defective; 
L6  x  differentiation-defective;  and  ED7  x  differentiation- 
defective  myoblasts.  Since  ED7 cells had a  higher chromo- 
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Differentiation Capacity of Hybrid Clones" 
Colonies  Myosin(+)  Total myosin(+)  Myosin(+) 
Cell combination  Karyotype  t  Typical colony size  counted  colonies  cells  cells 
%  % 
BU21  x  DD4a 
Clone 2  86  584/4  s  108  100  _t  99 
Clone 3  94  2,108/1,232  157  86  -  54 
Clone 4  85  2,108/1,860  78  87  -  46 
Clone 5  90  2,976/444  104  100  -  87 
Clone 6  92  1,460/464  175  98  -  75 
Clone 8  82  2,808/236  125  100  -  92 
Clone 10  90  2,319/429  275  98  -  82 
Clone 11  88  4,732/456  70  96  -  87 
Clone 12  86  776/356  58  98  -  68 
Clone 14  86  648/133  78  99  -  82 
Clone 15  96  380/187  47  96  -  64 
Clone 16  89  736/1,416  109  97  -  33 
Clone 17  86  380/187  47  96  -  64 
Clone 3'  111  2,056•376  76  93  -  79 
Clone 9'  85  1,776/340  122  100  -  84 
Clone 11'  88  684•272  73  100  -  72 
Clone 18'  94  972/560  105  95  -  62 
Clone 22'  95  425•93  76  99  -  81 
ED7 x  DD4a 
Clone 2  88  680  17  88  287  2.5 
Clone 4  86  1,001  65  54  8,272  12.7 
Clone 6  100  1,021  29  72  2,178  7.4 
Clone 11  94  793  20  95  1,923  12.1 
Clone 13  84  2,352  10  100  8,815  37.5 
Clone 15  95  704  23  87  492  3.0 
Clone 25  91  974  17  82  2,850  17.2 
Clone 32  98  650  20  90  3,690  28.4 
L6 x  DD4a 
Clone 2  62  912  21  95  1,471  7.7 
Clone 3  67  2,880  55  90  7,356  4.6 
Clone 12  64  492  15  67  615  8.3 
Clone 13  70  815  45  80  1,555  4.2 
Clone 14  57  907  38  74  1,302  3.8 
Clone 15  66  2,264  33  91  20,102  27.0 
Clone 16  66  1,116  36  72  6,488  16.0 
Clone 19  64  8,576  10  90  5,057  5.9 
Clone 21  63  1,860  29  90  6,711  12.4 
Clone 23  68  2,006  20  100  4,041  10.1 
* BU cycle 21  (BU21), early differentiating cycle 7 (ED7), and parental L6 myoblasts were each fused to differentiation-defective clone 4a 
(DD4a) cells. Each hybrid clone was subcultivated at clonal density, allowed to grow for 2 wk, fed differentiation-stimulating medium for 
1 wk, then immunoperoxidase-stained with antimyosin antibodies. The total number of nuclei in myosin(+) cells was counted for all the 
hybrids except BU21  x  DD4a (see s). The percent myosin(+) cells was calculated by dividing the total of myosin(+) cells by the product 
of the number of colonies counted and the number of cells per typical colony. 
t Cells were karyotyped in situ and counted under direct x400 observation. The number of chromosomes is the average of 3-6 metaphase 
spreads. Occasional spreads that were grossly different from the average for that particular colony were excluded from the analysis. BU21 
myoblasts have 65 chromosomes, ED7 cells have 75 chromosomes, and L6 and DD4a myoblasts have ~40 chromosomes. The expected 
chromosome  numbers are thus  105,  115, and 80 for  BU21  x  DD4a,  ED7  x  DD4a,  and  L6 x  DD4a  hybrids,  respectively. As  shown 
elsewhere (1),  in situ  karyotyping tends  to  underestimate the actual  number of chromosomes,  particularly in  hybrid cells  with  more 
overlapping chromosomes. 
s Typical colony sizes for BU21 xDD4a hybrids are expressed as a ratio of myosin(+) to myosin(-) cells. The number of myosin(+) cells in 
this combination was far too great to permit the total number to be actually counted. Instead, a typical colony was counted, and the total 
percent myosin(+) cells was estimated by multiplying the percent myosin(+) cells in a typical colony for the percent colonies that were 
myosin(+). 
some number than  BU21  myoblasts but lacked the BUdR- 
resistant phenotype, the potential contribution  of "non-spe- 
cific" gene dosage effects of increased chromosome numbers 
could be evaluated. The ability of all the sets of hybrid clones 
to differentiate was analyzed in the absence of BUdR. Table 
I presents the data from each hybrid clone. 
BU21  ×  differentiation-defective  cell  hybrids  showed  a 
much higher frequency of differentiation (geometric mean = 
71%) than L6 x  differentiation-defective hybrids (geometric 
mean  =  8%).  (The geometric mean  is given since the data 
vary in an exponential fashion [ 1  ]). The experimental protocol 
involved growing each hybrid clone as subclones for 2  wk, 
then  stimulating  them  to  differentiate  in  low  serum  plus 
insulin  for  1 wk before  analyzing for myosin-positive cells 
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entiation-defective  hybrids  was  so  great  that  most  of the 
subclones  had  become  massively fused  after 2-wk  growth 
without ever being exposed to differentiation-stimulating con- 
ditions. Since these hybrids had already become maximally 
differentiated before the end of the experiment, their relative 
capacity to differentiate was not fully assessed.  Nonetheless, 
they clearly showed an increased probability of differentiation 
as compared with the L6 x  differentiation-defective hybrids. 
The hybrids between ED7 and differentiation-defective my- 
oblasts  exhibited  a  probability  of differentiation  that  was 
approximately the same as the L6 x  differentiation-defective 
hybrids (geometric mean =  I 1%). These hybrids show that 
an increased gene-dosage effect from the myogenic-competent 
parent is not sufficient by itself to produce the dramatic rise 
in the probability of differentiation observed in the BU21  x 
differentiation-defective hybrids. 
DISCUSSION 
Cells resistant to the effect of BUdR generally either fail to 
transport BUdR across the plasma membrane or lack thymi- 
dine  kinase  and  fail to incorporate BUdR  into DNA.  The 
DNA density shift observed in cesium chloride gradients for 
myoblasts that  can  differentiate  in  the  presence of BUdR 
establishes that BUdR is entering the DNA and,  thus, that 
neither of the above explanations can account for the resistant 
phenotype. The ability of the cells to differentiate at lower 
cell densities when cloned in the absence of BUdR shows that 
BUdR is still having an inhibitory effect on cell differentiation 
and suggests that the cells are resistant due to a mechanism 
that overcomes rather than circumvents the action of BUdR. 
The very high levels of myogenesis observed in cell hybrids 
formed by fusing BU21  cells to differentiation-defective my- 
oblasts demonstrates that the BUdR-resistant phenotype be- 
haves in a  dominant fashion. A  variety of possible mecha- 
nisms might explain these results; for example, an increased 
level of phosphorylation of a  regulatory molecule or a  de- 
creased concentration of an inhibitory factor. However, we 
believe that the most likely and consistent explanation for the 
present and previous results (1,  5) is that the mechanism by 
which they have overcome the inhibitory effects of BUdR is 
by increasing the  expression  of the  factor(s) regulating the 
decision to differentiate. This could result from an amplifi- 
cation of the gene(s) coding for this factor(s) or an overprod- 
uction of the factor(s) from a single copy gene(s). The variants 
isolated in this study were obtained without overt mutagene- 
sis. Even though care was taken to avoid exposure of the cells 
to  light  of wavelengths <550  nm,  we  cannot  exclude  the 
possibility that  the  variants obtained  are actually mutants 
caused by the incorporation of BUdR. 
Approximately 2,000 colonies were examined and 15 clones 
were picked during each cycle of selection. Assuming that at 
least one additional variant was in fact isolated during each 
cycle, this represents a  frequency of roughly  10  -3. Since the 
frequency of gene reduplication is ~ 10  -3, and can be as high 
as 40% in the presence of DNA synthesis inhibitors (6), gene 
amplification could  easily be responsible for the  effect ob- 
tained during this stepwise selection.  Stepwise selection has 
been widely used to amplify genes coding for known enzymes 
that confer resistance to toxic drugs (reviewed in reference 6). 
The present experiments provide a novel application of step- 
wise  selection  to  potentially amplify the expression  of un- 
known  regulatory factors.  We are  attempting to  use  RNA 
from BUdR-resistant myoblasts to molecularly clone the fac- 
tors  regulating  terminal  differentiation.  If successful,  the 
probes obtained should permit one to detemine whether the 
expression of these  factors is increased and,  if so,  whether 
they are increased as a result ofgene amplification or increased 
transcription/translation/stability. 
An alternative to gene amplification as an explanation of 
the  phenotype  of BU21  cells  derives  from  the  studies  of 
Peterson  (15-17)  and  Pagen  (18).  They  have  shown  that 
quantitative variants in gene expression are constantly being 
generated  at  essentially  all  loci,  even  those  for  so-called 
"household functions." Peterson's model (17) states that the 
mean level of expression of a given product by a population 
of cells represents the steady state achieved by balancing the 
generation of variants having decreased levels of expression 
with those having increased levels of expression. Our previous 
studies had  suggested that differentiation-defective variants 
expressed decreased levels of the factors regulating the deci- 
sion to differentiate. Peterson's model suggested that if var- 
iants expressing a decreased level of these factors were con- 
stantly being generated then variants expressing an amplified 
level should  similarly be present.  In addition,  should  such 
amplified variants be isolated, they in turn  should generate 
cells  with  both  decreased  and  further  increased  levels  of 
expression, so that successive cycles of selection would pro- 
gressively increase the amplification obtained. The molecular 
basis for Peterson's mathematical model for quantitative var- 
iation is unknown and could well be gene amplification itself. 
Nonetheless, it provided a major theoretical rationale for the 
strategy  for  using  successive  cycles  of selection  to  isolate 
amplified myoblasts. 
Many  steps  probably intervene  between  the  decision  to 
differentiate and  the  expression  of differentiated  structural 
proteins. It is likely that BUdR effects multiple steps in this 
sequence  and  not just  the  initial  decision  to  differentiate. 
Since BU21  cells were selected only for their ability to form 
morphologically identifiable myotubes, the factors involved 
in other steps of terminal differentiation may not have been 
altered and thus may still be inhibited by BUdR. The exam- 
ination of changes in the coordinate regulation of different 
myogenic structural  proteins  during  cell  differentiation  of 
BU21 cells grown in the presence versus the absence of BUdR 
may provide some insight into the number of different regu- 
latory stages/sites involved. 
There are relatively few experimental models amenable to 
isolating genes involved in regulatory decisions. The selection 
for cells  able to overcome the  inhibition  of differentiation 
produced by BUdR appears to provide such a system. Since 
BUdR inhibits differentiation in a wide variety ofceU lineages 
(19-25),  its  use  may be  generalizable  for the  isolation  of 
variants with an amplified expression of factors regulating the 
decision to differentiate along several different pathways. It is 
hoped  that  such  studies  may ultimately shed  light  on  the 
elusive molecular mechanisms involved in determination and 
the commitment to terminal differentiation. 
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